The use of well-characterized human lung cancer cell lines has allowed for new opportunities in preclinical and clinical drug evaluation. Development of semiautomated tests of in vitro cytotoxicity such as the MTT assay, which utilizes the formazan salt 3-(4,~-dimethylthiazol-2-yl)-2,S-diphenyltetra
In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines
✍ Scribed by Henrik Roed; Lars L. Vindeløv; Mogens Spang-Thomsen; Ib J. Christensen; Heine Høi Hansen
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 299 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
✦ Synopsis
The cytotoxic activity of a new nitrosourea, TCNU, was compared with that of BCNU in five human small cell lung cancer cell lines in vitro. TCNU was found to be equivalent or inferior to BCNU when compared on a microgram to microgram basis. If the potential of in vitro phase II trials for selection of new drugs can be validated, it can be concluded that TCNU is not superior to other nitrosoureas for the treatment of SCCL.
📜 SIMILAR VOLUMES
Three cell lines derived from small-cell lung carcinoma (SCLC) tumors of patients who had no clinical response after treatment with a multi-drug regimen were compared to 3 cell lines derived from tumors of patients who, upon treatment, showed a complete clinical response. These 2 groups of cell line